What is Novavax's current debt?

Novavax (NVAX) reported current debt of $2.11M in Q1 2026.

How has Novavax's current debt changed year-over-year?

Novavax's current debt decreased by 61.4% year-over-year, from $5.48M to $2.11M.

What is the long-term trend for Novavax's current debt?

Over 5 years (2020 to 2025), Novavax's current debt has grown at a -52.7% compound annual growth rate (CAGR), from $105.86M to $2.51M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Novavax NVAX Current Debt

Current Debt at other companies

Gilead SciencesGILD

$1.31B-53.2%

BioCryst PharmaceuticalsBCRX

$1.24M-31.2%

ModernaMRNA

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's current debt?: Novavax (NVAX) reported current debt of $2.11M in Q1 2026.
How has Novavax's current debt changed year-over-year?: Novavax's current debt decreased by 61.4% year-over-year, from $5.48M to $2.11M.
What is the long-term trend for Novavax's current debt?: Over 5 years (2020 to 2025), Novavax's current debt has grown at a -52.7% compound annual growth rate (CAGR), from $105.86M to $2.51M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.